The willingness of people who inject drugs in Boston to use a supervised injection facility - PubMed (original) (raw)
The willingness of people who inject drugs in Boston to use a supervised injection facility
Casey León et al. Subst Abus. 2018.
Abstract
Background: In Massachusetts, the number of opioid-related deaths has increased 350% since 2000. In the setting of increasing overdose deaths, one potential intervention is supervised injection facilities (SIFs). This study explores willingness of people who inject drugs in Boston to use a SIF and examines factors associated with willingness.
Methods: A cross-sectional survey of a convenience sample of 237 people who inject drugs and utilize Boston's needle exchange program (NEP). The drop-in NEP provides myriad harm reduction services and referrals to addiction treatment. The survey was mostly self-administered (92%).
Results: Results showed positive willingness to use a SIF was independently associated with use of heroin as main substance (odds ratio [OR]: 5.47; 95% confidence interval [CI]: 1.9-15.4; P = .0004), public injection (OR: 5.09; 95% CI: 1.8-14.3; P = .002), history of seeking substance use disorder (SUD) treatment (OR: 4.99; 95% CI: 1.2-21.1; P = .05), having heard of SIF (OR: 4.80; 95% CI: 1.6-14.8; P = .004), Hispanic ethnicity (OR: 4.22; 95% CI: 0.9-18.8; P = .04), frequent NEP use (OR: 4.18; 95% CI: 1.2-14.7; P = .02), current desire for SUD treatment (OR: 4.15; 95% CI: 1.2-14.7; P = .03), hepatitis C diagnosis (OR: 3.68; 95% CI: 1.2-10.1; P = .02), posttraumatic stress disorder (PTSD) diagnosis (OR: 3.27; 95% CI: 1.3-8.4; P = .01), report of at least 1 chronic medical diagnosis (hepatitis C, human immunodeficiency virus [HIV], hypertension, or diabetes) (OR: 3.27; 95% CI: 1.2-8.9; P = .02), and comorbid medical and mental health diagnoses (OR: 2.93; 95% CI: 1.2-7.4; P = .02).
Conclusions: Most respondents (91.4%) reported willingness to use a SIF. Respondents with substance use behavior reflecting high risk for overdose were significantly more likely to be willing to use a SIF. Respondents with behaviors that contribute to public health burden of injection drug use were also significantly more likely to be willing to use a SIF. Results indicate that this intervention would be well utilized by individuals who could most benefit from the model. As part of a broader public health approach, SIFs should be considered to reduce opioid overdose mortality, decrease public health burden of the opioid crisis, and promote access to addiction treatment and medical care.
Keywords: Opioid overdose; opioid use disorder; supervised injection facility.
Similar articles
- Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Bouvier BA, et al. Harm Reduct J. 2017 Feb 20;14(1):13. doi: 10.1186/s12954-017-0139-0. Harm Reduct J. 2017. PMID: 28219388 Free PMC article. - Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC, Hayashi K, Milloy MJ, Wood E, Kerr T. Kennedy MC, et al. PLoS Med. 2019 Nov 26;16(11):e1002964. doi: 10.1371/journal.pmed.1002964. eCollection 2019 Nov. PLoS Med. 2019. PMID: 31770391 Free PMC article. - Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE, Richardson J, Frasso R, Anderson ED. Harris RE, et al. Int J Drug Policy. 2018 Feb;52:56-61. doi: 10.1016/j.drugpo.2017.11.005. Epub 2017 Dec 10. Int J Drug Policy. 2018. PMID: 29241143 - Supervised injection facilities in Canada: past, present, and future.
Kerr T, Mitra S, Kennedy MC, McNeil R. Kerr T, et al. Harm Reduct J. 2017 May 18;14(1):28. doi: 10.1186/s12954-017-0154-1. Harm Reduct J. 2017. PMID: 28521829 Free PMC article. Review. - Supervised Injection Facilities as Harm Reduction: A Systematic Review.
Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, Bazzi AR. Levengood TW, et al. Am J Prev Med. 2021 Nov;61(5):738-749. doi: 10.1016/j.amepre.2021.04.017. Epub 2021 Jul 1. Am J Prev Med. 2021. PMID: 34218964 Free PMC article. Review.
Cited by
- Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC. Park JN, et al. J Urban Health. 2019 Jun;96(3):353-366. doi: 10.1007/s11524-019-00365-1. J Urban Health. 2019. PMID: 31168735 Free PMC article. - Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.
Tan M, Park C, Goldman J, Biello KB, Buxton J, Hadland SE, Park JN, Sherman SG, Macmadu A, Marshall BDL. Tan M, et al. Harm Reduct J. 2024 Feb 29;21(1):54. doi: 10.1186/s12954-024-00969-0. Harm Reduct J. 2024. PMID: 38424553 Free PMC article. - Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian Setting.
Ickowicz S, Grant C, Nosova E, Boyd J, Brar R, Milloy MJ, Hayashi K, Nolan S. Ickowicz S, et al. J Addict Med. 2020 Sep/Oct;14(5):e226-e232. doi: 10.1097/ADM.0000000000000646. J Addict Med. 2020. PMID: 32142059 Free PMC article. - Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study.
Cleirec G, Fortias M, Bloch V, Clergue-Duval V, Bellivier F, Dusouchet T, Debaulieu C, Vorspan F. Cleirec G, et al. Harm Reduct J. 2018 Oct 25;15(1):53. doi: 10.1186/s12954-018-0260-8. Harm Reduct J. 2018. PMID: 30359272 Free PMC article. - Support for Safe Consumption Sites Among Peer Recovery Coaches.
Pasman E, Brown S, Agius E, Resko SM. Pasman E, et al. J Behav Health Serv Res. 2024 Apr;51(2):219-231. doi: 10.1007/s11414-023-09846-3. Epub 2023 Jul 10. J Behav Health Serv Res. 2024. PMID: 37430133
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials